There is a good chance GeneDx Holdings Corp. (WGS) will undergo another restructuring.

The price of GeneDx Holdings Corp. (NASDAQ: WGS) closed at $0.35 in the last session, up 1.46% from day before closing price of $0.35. In other words, the price has increased by $+0.0051 from its previous closing price. On the day, 3481496 shares were traded. WGS stock price reached its highest trading level at $0.3729 during the session, while it also had its lowest trading level at $0.3106.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



We take a closer look at WGS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.60 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.

Upgrades & Downgrades

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 10 when Stueland Katherine sold 92,644 shares for $0.36 per share. The transaction valued at 33,333 led to the insider holds 308,574 shares of the business.

Saad Kareem sold 35,200 shares of WGS for $12,665 on Mar 10. The Chief Transformation Officer now owns 178,430 shares after completing the transaction at $0.36 per share. On Mar 10, another insider, White Karen Ann, who serves as the Chief People Officer of the company, sold 32,787 shares for $0.36 each. As a result, the insider received 11,797 and left with 52,172 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1.41 while its Price-to-Book (P/B) ratio in mrq is 0.24.

Stock Price History:

Over the past 52 weeks, WGS has reached a high of $3.28, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 0.4146, while the 200-Day Moving Average is calculated to be 0.9518.

Shares Statistics:

According to the various share statistics, WGS traded on average about 3.70M shares per day over the past 3-months and 4.67M shares per day over the past 10 days. A total of 380.76M shares are outstanding, with a floating share count of 198.51M. Insiders hold about 0.30% of the company’s shares, while institutions hold 41.10% stake in the company. Shares short for WGS as of Jan 12, 2023 were 6.23M with a Short Ratio of 7.54M, compared to 6.38M on Nov 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.61% and a Short% of Float of 2.42%.

Earnings Estimates

The company has 3 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.16 for the current quarter, with a high estimate of -$0.13 and a low estimate of -$0.19, while EPS last year was -$0.17. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.05 and low estimates of -$0.14.

Analysts are recommending an EPS of between -$0.79 and -$0.88 for the fiscal current year, implying an average EPS of -$0.83. EPS for the following year is -$0.38, with 3 analysts recommending between -$0.22 and -$0.53.

Revenue Estimates

According to 4 analysts, the current quarter’s revenue is expected to be $70.95M. It ranges from a high estimate of $75.96M to a low estimate of $60M. As of the current estimate, GeneDx Holdings Corp.’s year-ago sales were $57.8M, an estimated increase of 22.70% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $48.26M, a decrease of -10.50% less than the figure of $22.70% in the same quarter last year. There is a high estimate of $52.7M for the next quarter, whereas the lowest estimate is $43.15M.

A total of 4 analysts have provided revenue estimates for WGS’s current fiscal year. The highest revenue estimate was $249.31M, while the lowest revenue estimate was $233.3M, resulting in an average revenue estimate of $244.27M. In the same quarter a year ago, actual revenue was $212.19M, up 15.10% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $217.84M in the next fiscal year. The high estimate is $225M and the low estimate is $209.37M. The average revenue growth estimate for next year is down -10.80% from the average revenue estimate for this year.